Life Science Access Academy Ltd invites you to their event

Haematology NHS Update with Julie Worth and Khaleel Loonat

About this event

How can you work more effectively with the NHS to deliver haematology services?

Masterclass Details:

In this insightful 60-minute masterclass for LSAA members, Khaleel Loonat and Julie Worth will discuss the future for haematology life science interventions.

As we edge closer to a new NHS financial year, with the prospect of yet more significant strategic and tactical change, this masterclass will help you identify the challenges and opportunities to enhance patient outcomes.

Khaleel brings a wealth of clinical pharmacy experience and will be on hand for Q+As - this is an opportunity you will not want to miss!

Key Learning Objectives:

  • How haematology services are currently being delivered and funded
  • How they will be affected by the introduction of integrated care systems, at system, place and neighbourhood levels
  • Challenges to haematology provision
  • How you can work more effectively with the NHS to deliver haematology services

Click our logo below to see our other masterclasses:

Hosted by

  • Guest speaker
    Khaleel Loonat Director @ FSK Healthcare Ltd

    Khaleel is a clinical and practicing pharmacist providing consulting services to Pharmaceutical companies across several therapeutic areas.

  • Guest speaker
    Julie Worth

    With 28 years of experience in the pharmaceutical industry, Julie’s career spans commercial and leadership roles in both Global and SME-size organisations.

  • Team member
    Ian Chamberlain Managing Director @ Life Science Access Academy

    Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.

Life Science Access Academy Ltd

LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.